Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ovarian Carcinoma, Recurrent”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT01249443
What this trial is testing

Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection

Who this might be right for
HIV InfectionRecurrent Anal CancerRecurrent Breast Cancer+31 more
AIDS Malignancy Consortium 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT01116648
What this trial is testing

Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer

Who this might be right for
Fallopian Tube CarcinomaOvarian Endometrioid AdenocarcinomaOvarian High Grade Serous Adenocarcinoma+4 more
National Cancer Institute (NCI) 155
Early research (Phase 1)Study completedNCT02028117
What this trial is testing

Phase I / Dose Expansion Study of Enadenotucirev in Ovarian Cancer Patients

Who this might be right for
Recurrent Platinum Resistant Ovarian Cancer
Akamis Bio 38
Testing effectiveness (Phase 2)Study completedNCT00610740
What this trial is testing

CerviPrep for Applying Topical Gemcitabine to the Cervix in Treating Patients With Primary Endometrial, Cervical, or Ovarian Epithelial Cancer

Who this might be right for
Cervical CancerEndometrial CancerOvarian Cancer
Masonic Cancer Center, University of Minnesota 18
Early research (Phase 1)Looking for participantsNCT06930755
What this trial is testing

Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer

Who this might be right for
Ovarian Cancer
Nerviano Medical Sciences 24
Testing effectiveness (Phase 2)Study completedNCT00087087
What this trial is testing

Pemetrexed Disodium in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPrimary Peritoneal Cavity Cancer
Gynecologic Oncology Group 51
Testing effectiveness (Phase 2)Study completedNCT00019916
What this trial is testing

Vaccine Therapy Plus Interleukin-2 in Treating Women With Stage IV, Recurrent, or Progressive Breast or Ovarian Cancer

Who this might be right for
Breast CancerOvarian Cancer
National Cancer Institute (NCI)
Large-scale testing (Phase 3)UnknownNCT04337632
What this trial is testing

Evaluation of the Sensitivity to Different Chemotherapy Regimens in Platinum-Partial Sensitive Recurrent Ovarian Cancer

Who this might be right for
Ovarian Cancer
Hunan Cancer Hospital 338
Testing effectiveness (Phase 2)Active Not RecruitingNCT03836352
What this trial is testing

Study of an Immunotherapeutic, DPX-Survivac, in Combination With Low Dose Cyclophosphamide & Pembrolizumab, in Subjects With Selected Advanced & Recurrent Solid Tumors

Who this might be right for
Ovarian CancerHepatocellular CarcinomaNon-small Cell Lung Cancer+2 more
ImmunoVaccine Technologies, Inc. (IMV Inc.) 184
Testing effectiveness (Phase 2)Ended earlyNCT00247988
What this trial is testing

Weekly Carboplatin and Taxotere in Platinum Sensitive Relapsed Ovarian or Tubal or Primary Peritoneal Cancers

Who this might be right for
Platinum Sensitive Relapsed Ovarian Cancer
University of Saskatchewan 38
Testing effectiveness (Phase 2)Study completedNCT00170573
What this trial is testing

Caelyx Biweekly in Heavily Pretreated Patients With Relapsed Ovarian Cancer

Who this might be right for
Ovarian Cancer
North Eastern German Society of Gynaecological Oncology 77
Not applicableWithdrawnNCT00787488
What this trial is testing

Pilot Study of IV and IP Chemotherapy Plus Abdominal Hyperthermia for Ovarian Ca

Who this might be right for
Ovarian Cancer
Mark Dewhirst
Testing effectiveness (Phase 2)Study completedNCT02759588
What this trial is testing

Olvi-Vec Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian Cancer

Who this might be right for
Ovarian CancerPeritoneal CarcinomatosisFallopian Tube Cancer
Genelux Corporation 46
Testing effectiveness (Phase 2)Ended earlyNCT01312389
What this trial is testing

A Clinical Trial of Autologous Oxidized Tumor Cell Lysate Vaccine For Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Abramson Cancer Center at Penn Medicine 3
Testing effectiveness (Phase 2)UnknownNCT04091204
What this trial is testing

Olaparib in Patients With Recurrent Ovarian Cancer Wild Type for Germline and Somatic BRCA 1 and 2 Genes: The MITO 31 Translational Study

Who this might be right for
BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer
National Cancer Institute, Naples 200
Testing effectiveness (Phase 2)Ended earlyNCT04814875
What this trial is testing

Evaluate the Combination of ATX-101 and Platinum-based Chemotherapy

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma+1 more
THERAPIM PTY LTD 16
Testing effectiveness (Phase 2)Study completedNCT00103545
What this trial is testing

Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response

Who this might be right for
Ovarian CancerFallopian Tube NeoplasmsPeritoneal Neoplasms
AGO Study Group 36
Testing effectiveness (Phase 2)Looking for participantsNCT04518501
What this trial is testing

Fuzuloparib Arsenic Trioxide Platinum Resistance Relapsed Ovarian Cancer

Who this might be right for
Efficacy and Safety
Xing Xie 50
Early research (Phase 1)Study completedNCT01074411
What this trial is testing

Intraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Fallopian Tube Clear Cell AdenocarcinomaFallopian Tube Endometrioid AdenocarcinomaFallopian Tube Mucinous Adenocarcinoma+17 more
National Cancer Institute (NCI) 33
Early research (Phase 1)Study completedNCT03213964
What this trial is testing

Intraperitoneal Delivery of Adaptive Natural Killer (NK) Cells (FATE-NK100) With Intraperitoneal Int

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Masonic Cancer Center, University of Minnesota 10
Next Page